BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 17952864)

  • 21. Beta-catenin degradation mediated by the CID domain of APC provides a model for the selection of APC mutations in colorectal, desmoid and duodenal tumours.
    Kohler EM; Chandra SH; Behrens J; Schneikert J
    Hum Mol Genet; 2009 Jan; 18(2):213-26. PubMed ID: 18854359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Approach to screening for Familial Adenomatous Polyposis (FAP) in a cohort of 226 patients with Desmoid-type Fibromatosis (DF): experience of a specialist center in the UK.
    Cojocaru E; Gennatas S; Thway K; Fisher C; Smrke A; Strauss D; Hayes A; Smith M; Jones RL; Benson C; McVeigh TP
    Fam Cancer; 2022 Jan; 21(1):69-74. PubMed ID: 33547536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A germline mutation at the extreme 3' end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumor.
    Couture J; Mitri A; Lagace R; Smits R; Berk T; Bouchard HL; Fodde R; Alman B; Bapat B
    Clin Genet; 2000 Mar; 57(3):205-12. PubMed ID: 10782927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel pathogenic alterations in pediatric and adult desmoid-type fibromatosis - A systematic analysis of 204 cases.
    Trautmann M; Rehkämper J; Gevensleben H; Becker J; Wardelmann E; Hartmann W; Grünewald I; Huss S
    Sci Rep; 2020 Feb; 10(1):3368. PubMed ID: 32099073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adenomatous polyposis coli gene and beta-catenin gene mutations in desmoid-type fibromatosis].
    Yang JL; Wang J; Zhou XY; Hou YY; Zhu XZ
    Zhonghua Bing Li Xue Za Zhi; 2006 Apr; 35(4):237-8. PubMed ID: 16776983
    [No Abstract]   [Full Text] [Related]  

  • 26. Human microRNA expression in sporadic and FAP-associated desmoid tumors and correlation with beta-catenin mutations.
    Cavallini A; Rotelli MT; Lippolis C; Piscitelli D; Digennaro R; Covelli C; Carella N; Accetturo M; Altomare DF
    Oncotarget; 2017 Jun; 8(26):41866-41875. PubMed ID: 28418912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aggressive fibromatosis.
    Fisher C; Thway K
    Pathology; 2014 Feb; 46(2):135-40. PubMed ID: 24378386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers.
    Gaujoux S; Pinson S; Gimenez-Roqueplo AP; Amar L; Ragazzon B; Launay P; Meatchi T; Libé R; Bertagna X; Audebourg A; Zucman-Rossi J; Tissier F; Bertherat J
    Clin Cancer Res; 2010 Nov; 16(21):5133-41. PubMed ID: 20978149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wnt targets genes are not differentially expressed in desmoid tumors bearing different activating β-catenin mutations.
    Timbergen MJM; Janssen ML; Verhoef C; Grünhagen DJ; Chibon F; Smid M; Sleijfer S; Wiemer EAC
    Eur J Surg Oncol; 2019 Apr; 45(4):691-698. PubMed ID: 30528042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian steroid cell tumor with biallelic adenomatous polyposis coli inactivation in a patient with familial adenomatous polyposis.
    Hu PJ; Knoepp SM; Wu R; Cho KR
    Genes Chromosomes Cancer; 2012 Mar; 51(3):283-9. PubMed ID: 22120905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis).
    Kummar S; O'Sullivan Coyne G; Do KT; Turkbey B; Meltzer PS; Polley E; Choyke PL; Meehan R; Vilimas R; Horneffer Y; Juwara L; Lih A; Choudhary A; Mitchell SA; Helman LJ; Doroshow JH; Chen AP
    J Clin Oncol; 2017 May; 35(14):1561-1569. PubMed ID: 28350521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between beta-catenin widespread nuclear expression and matrix metalloproteinase-7 overexpression in sporadic desmoid tumors.
    Matono H; Oda Y; Nakamori M; Tamiya S; Yamamoto H; Yokoyama R; Saito T; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2008 Dec; 39(12):1802-8. PubMed ID: 18715618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic testing for germline mutations of the APC gene in patients with apparently sporadic desmoid tumors but a family history of colorectal carcinoma.
    Brueckl WM; Ballhausen WG; Förtsch T; Günther K; Fiedler W; Gentner B; Croner R; Boxberger F; Kirchner T; Hahn EG; Hohenberger W; Wein A
    Dis Colon Rectum; 2005 Jun; 48(6):1275-81. PubMed ID: 15793634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormalities of the Wnt/β-catenin signalling pathway induce tumour progression in sporadic desmoid tumours: correlation between β-catenin widespread nuclear expression and VEGF overexpression.
    Matono H; Tamiya S; Yokoyama R; Saito T; Iwamoto Y; Tsuneyoshi M; Oda Y
    Histopathology; 2011 Sep; 59(3):368-75. PubMed ID: 22034877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin-regulatory function in aggressive fibromatosis (desmoid tumor).
    Li C; Bapat B; Alman BA
    Am J Pathol; 1998 Sep; 153(3):709-14. PubMed ID: 9736021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coexistence of somatic and germ-line mutations of APC gene in desmoid tumors from patients with familial adenomatous polyposis.
    Miyaki M; Konishi M; Kikuchi-Yanoshita R; Enomoto M; Tanaka K; Takahashi H; Muraoka M; Mori T; Konishi F; Iwama T
    Cancer Res; 1993 Nov; 53(21):5079-82. PubMed ID: 8221638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Desmoid tumors: clinical features and treatment options for advanced disease.
    Kasper B; Ströbel P; Hohenberger P
    Oncologist; 2011; 16(5):682-93. PubMed ID: 21478276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of cultured desmoid cells with different CTNNB1 mutation status.
    Hamada S; Urakawa H; Kozawa E; Arai E; Ikuta K; Sakai T; Ishiguro N; Nishida Y
    Cancer Med; 2016 Feb; 5(2):352-60. PubMed ID: 26686699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting stem cell behavior in desmoid tumors (aggressive fibromatosis) by inhibiting hedgehog signaling.
    Ghanbari-Azarnier R; Sato S; Wei Q; Al-Jazrawe M; Alman BA
    Neoplasia; 2013 Jul; 15(7):712-9. PubMed ID: 23814483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal therapy for desmoid tumors: current options and challenges for the future.
    Al-Jazrawe M; Au M; Alman B
    Expert Rev Anticancer Ther; 2015; 15(12):1443-58. PubMed ID: 26472625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.